Detalhe da pesquisa
1.
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis.
Kidney Int
; 105(1): 31-34, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38182299
2.
Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of ANCA-Associated Vasculitis.
Kidney Int
; 105(3): 447-449, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38388147
3.
Efficacy and safety of a targeted-release formulation of budesonide in patients with primary IgA nephropathy (NefIgArd): 2-year results from a randomised phase 3 trial.
Lancet
; 402(10405): 859-870, 2023 09 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37591292
4.
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Lancet
; 402(10417): 2077-2090, 2023 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37931634
5.
IgA nephropathy: the lectin pathway and implications for targeted therapy.
Kidney Int
; 104(2): 254-264, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37263354
6.
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Kidney Int
; 103(2): 391-402, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270561
7.
Two-Year, Randomized, Controlled Trial of Belimumab in Lupus Nephritis.
N Engl J Med
; 383(12): 1117-1128, 2020 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32937045
8.
Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial.
Nephrol Dial Transplant
; 38(12): 2733-2742, 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37463054
9.
The lupus nephritis management renaissance.
Kidney Int
; 101(2): 242-255, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34619230
10.
The cell membrane repair protein MG53 modulates transcription factor NF-κB signaling to control kidney fibrosis.
Kidney Int
; 101(1): 119-130, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34757120
11.
Prediction models of treatment response in lupus nephritis.
Kidney Int
; 101(2): 379-389, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34871620
12.
A secondary analysis of the Belimumab International Study in Lupus Nephritis trial examined effects of belimumab on kidney outcomes and preservation of kidney function in patients with lupus nephritis.
Kidney Int
; 101(2): 403-413, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34560137
13.
Molecular profiling of kidney compartments from serial biopsies differentiate treatment responders from non-responders in lupus nephritis.
Kidney Int
; 102(4): 845-865, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788359
14.
Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.
Lancet
; 397(10289): 2070-2080, 2021 05 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-33971155
15.
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
N Engl J Med
; 381(1): 36-46, 2019 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31269364
16.
B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial.
Ann Rheum Dis
; 81(1): 100-107, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34615636
17.
Improving Clinical Trials for Anticomplement Therapies in Complement-Mediated Glomerulopathies: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Am J Kidney Dis
; 79(4): 570-581, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34571062
18.
Controversies in Systemic Lupus Erythematosus 2021: Changing the Paradigm in the Management of Lupus Nephritis.
J Clin Rheumatol
; 28(4): 229-233, 2022 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616510
19.
A multimodal and integrated approach to interrogate human kidney biopsies with rigor and reproducibility: guidelines from the Kidney Precision Medicine Project.
Physiol Genomics
; 53(1): 1-11, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33197228
20.
The STARMEN trial: rethinking calcineurin inhibitor therapy in membranous nephropathy.
Kidney Int
; 99(4): 811-813, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33745547